Drug Helps Women Battle Ovarian Cancer

The video discusses the impact of the drug Avastin on ovarian cancer patients. A patient shares her journey from fearing the worst to being in remission, thanks to a clinical trial involving Avastin. The drug has been approved by the European Medicines watchdog, offering hope to others. Ovarian cancer is often diagnosed late, with only 41% surviving five years post-diagnosis. Avastin extends life by an average of six months for advanced cancer patients. While not a cure, it provides hope and is available through the Cancer Drugs Fund in England.

What new insight or understanding did you gain from this video?